Medication info
Exozole Tablet 40 mg (Esomeprazole Magnesium Trihydrate)

Exozole Tablet 40 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›43.38mg / 1 tablet
Manufacturer / importer
Samil Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
14 tablets/blister X 2
Approval status
Active

MFDS item code 201504201 · Approved 2015.06.29 · Insurance code 643903410

Summary

Main use
Treatment of acid-related disorders (reflux and Zollinger-Ellison syndrome), Helicobacter pylori infection and ulcers, and gastrointestinal disorders caused by anti-inflammatory drugs
Who uses it
Adults · Children
Adult dosage
Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Long-term maintenance therapy to prevent relapse in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have resolved, control subsequent recurring symptoms by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The dose should subsequently be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided into 2 doses per day. Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration. No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal failure. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed a dose of 20 mg of this medicine. No dose adjustment is necessary.
Children's dosage
Adolescents 12 years of age or older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents 12 years of age or older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents 12 years of age or older: Once symptoms have resolved, control subsequent recurring symptoms by administering 20 mg once daily. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.

Ingredients

Manufacturer
Samil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (reflux and Zollinger-Ellison syndrome), Helicobacter pylori infection and ulcers, and gastrointestinal disorders caused by anti-inflammatory drugs

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • Helicobacter pylori positive duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers related to non-steroidal anti-inflammatory drug use
  • duodenal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used not only for the treatment of gastroesophageal reflux disease and erosive esophagitis but also as a long-term maintenance therapy to prevent recurrent esophagitis. It is effective for the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection. It also helps relieve gastrointestinal symptoms and ulcers that may occur while taking non-steroidal anti-inflammatory drugs. It is used in the treatment of Zollinger-Ellison syndrome and for maintenance therapy to prevent rebleeding of gastric or duodenal ulcers, improving gastrointestinal health.

Dosage and Administration

Adult dosage

Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Long-term maintenance therapy to prevent relapse in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have resolved, control subsequent recurring symptoms by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The dose should subsequently be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided into 2 doses per day. Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration. No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal failure. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed a dose of 20 mg of this medicine. No dose adjustment is necessary.

Children's dosage

Adolescents 12 years of age or older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents 12 years of age or older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents 12 years of age or older: Once symptoms have resolved, control subsequent recurring symptoms by administering 20 mg once daily. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.

Precautions

This medication should not be used in certain patients. For example, individuals who are allergic to this medication or its components, or those with hypersensitivity to certain antibiotics should not take it. Moreover, those currently taking specific heart-related medications or with a history of myocardial infarction, as well as breastfeeding individuals, should not use this medication. Various side effects may occur while taking this medication. Gastrointestinal symptoms such as headache, abdominal pain, diarrhea, and nausea, as well as skin rashes, itching, and in rare cases severe allergic reactions or blood abnormalities might occur. Additionally, there have been reports of hypomagnesemia, liver dysfunction, and muscle pain, so if symptoms appear, consult a doctor immediately. Regular check-ups are necessary for long-term use of this medication, and if symptoms suggest malignancy, it is essential to confirm malignancy before use. This medication lowers gastric acidity and may increase the risk of bacterial infection in the gastrointestinal tract, so if diarrhea persists, consult healthcare professionals. This medication has many interactions with other drugs; therefore, caution is needed when co-administered with antivirals, antibiotics, anticoagulants, and antidepressants. If you are taking other medications, you must inform your healthcare provider, as drug interactions could alter effectiveness or increase the risk of side effects. Pregnant or breastfeeding women must consult a doctor before using this medication, and it is safer for breastfeeding individuals to avoid using this drug. In the case of overdose, there are no specific antidotes, so adequate treatment should be based on symptoms, and it is important to keep it out of reach of children.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized pustular psoriasis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, renal tubular acidosis, gynecomastia, asthenia, increased sweating, Clostridium difficile infection diarrhea, abdominal distension, allergic reaction, back pain, chest pain, substernal pain, facial swelling, facial flushing, fatigue, flu-like symptoms, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, exacerbation of constipation, dyspepsia, swallowing difficulties, gastrointestinal malformation, epigastric pain, belching, esophageal disturbances, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disturbances, pharyngeal disturbances, rectal disturbances, gastrointestinal symptoms, increased serum gastrin, tongue disturbances, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, appetite loss, apathy, increased appetite, confusion, exacerbation of depression, muscular hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremor, visual impairment, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, dysosmia, ageusia, disgeusia, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture. It is best to maintain a room temperature of between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a long time.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

14 tablets/blister X 2

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.